Health Canada’s regulatory response to COVID-19: International engagement

Health Canada’s regulatory response to COVID-19: International engagement During the COVID-19 pandemic, Health Canada is working closely with domestic and international partners to anticipate and meet Canadians' health product needs. This involves discussing, collaborating and leveraging resources on issues related to clinical trials and investigational testing, drug and medical device market authorizations, health product risk assessments, and potential drug and medical device shortages. 2022-06-07 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyclinical trialsinvestigational testinginternational engagementdomestic-and-international partnerscollaborating and leveraging-resourcesregulatory-response to COVID-19market authorizationshealth-product risk assessmentsdrug shortagesmedical device shortages Health Canada’s regulatory response to COVID-19: International engagementHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/engaging-international-partners.html Health Canada’s regulatory response to COVID-19: International engagementHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/collaboration-partenaires-internationaux.html

During the COVID-19 pandemic, Health Canada is working closely with domestic and international partners to anticipate and meet Canadians' health product needs. This involves discussing, collaborating and leveraging resources on issues related to clinical trials and investigational testing, drug and medical device market authorizations, health product risk assessments, and potential drug and medical device shortages.

Data and Resources

Similar records